Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 7, 2020. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2020. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 23.1B USD
- Positions
- 72
- Share of the ten largest
- 44.3%
The ten largest positions Q2 2020
- Amazon 7.3%▼ −30.4%
- Adaptive Biotechnologies Cor 7.0%unchanged
- Comcast 4.8%▲ +59.3%
- Centene Corporation 4.4%▼ −0.8%
- American Express 4.3%▲ +170.7%
- Fidelity National Information Services 3.9%▲ +76.7%
- Bridgebio Pharma Inc 3.8%unchanged
- Microsoft 3.3%▼ −24.3%
- Boston Scientific 2.8%▼ −42.0%
- Thermo Fisher Scientific 2.7%new
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q2 2020
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| AMZN Amazon | 7.3% | 612,886 | 1.7B USD | −30.4% reduced | Q2 2015 21 quarters |
| Adaptive Biotechnologies Cor | 7.0% | 33,493,708 | 1.6B USD | unchanged | Q2 2019 5 quarters |
| CMCSA Comcast | 4.8% | 28,523,676 | 1.1B USD | +59.3% increased | Q4 2019 3 quarters |
| CNC Centene Corporation | 4.4% | 16,106,578 | 1.0B USD | −0.8% reduced | Q2 2018 9 quarters |
| AXP American Express | 4.3% | 10,497,498 | 999.4M USD | +170.7% increased | Q1 2020 2 quarters |
| FIS Fidelity National Information Services | 3.9% | 6,714,021 | 900.3M USD | +76.7% increased | Q4 2019 3 quarters |
| Bridgebio Pharma Inc | 3.8% | 26,620,991 | 868.1M USD | unchanged | Q2 2019 5 quarters |
| MSFT Microsoft | 3.3% | 3,710,674 | 755.2M USD | −24.3% reduced | Q2 2016 17 quarters |
| BSX Boston Scientific | 2.8% | 18,457,273 | 648.0M USD | −42.0% reduced | Q3 2018 8 quarters |
| TMO Thermo Fisher Scientific | 2.7% | 1,734,144 | 628.4M USD | new | Q2 2020 1 quarter |
| JPM JPMorgan Chase | 2.6% | 6,411,486 | 603.1M USD | +56.9% increased | Q1 2020 2 quarters |
| FTV Fortive | 2.6% | 8,760,046 | 592.7M USD | −7.0% reduced | Q3 2019 4 quarters |
| AON Aon plc | 2.5% | 2,956,029 | 569.3M USD | +29.1% increased | Q3 2018 8 quarters |
| CI Cigna | 2.4% | 2,949,644 | 553.5M USD | +15.8% increased | Q4 2019 3 quarters |
| HLT Hilton Worldwide | 2.3% | 7,272,455 | 534.2M USD | new | Q2 2020 1 quarter |
| UBER Uber | 2.2% | 16,470,839 | 511.9M USD | −37.2% reduced | Q2 2019 5 quarters |
| LVS Las Vegas Sands | 2.2% | 11,125,343 | 506.6M USD | +259.5% increased | Q1 2020 2 quarters |
| JD JD.com (ADR) | 2.1% | 8,266,459 | 497.5M USD | −56.2% reduced | Q1 2019 6 quarters |
| Api Group Corp | 1.8% | 33,333,333 | 405.0M USD | new | Q2 2020 1 quarter |
| CRM Salesforce | 1.7% | 2,145,463 | 401.9M USD | −38.8% reduced | Q2 2019 5 quarters |
| TMUS T-Mobile US | 1.7% | 3,799,550 | 395.7M USD | +203.0% increased | Q1 2020 2 quarters |
| Nuance Communications Inc | 1.4% | 12,799,556 | 323.9M USD | new | Q2 2020 1 quarter |
| BKNG Booking Holdings | 1.4% | 202,747 | 322.8M USD | +8.5% increased | Q4 2019 3 quarters |
| AIZ Assurant | 1.3% | 2,826,277 | 291.9M USD | +31.6% increased | Q2 2019 5 quarters |
| IR Ingersoll Rand | 1.2% | 10,196,427 | 286.7M USD | −15.1% reduced | Q1 2020 2 quarters |
| WDAY Workday, Inc. | 1.2% | 1,490,882 | 279.3M USD | −39.4% reduced | Q1 2020 2 quarters |
| CB Chubb Limited | 1.2% | 2,202,033 | 278.8M USD | +139.7% increased | Q1 2020 2 quarters |
| MCO Moody's Corporation | 1.2% | 977,348 | 268.5M USD | new | Q2 2020 1 quarter |
| PH Parker Hannifin | 1.1% | 1,442,793 | 264.4M USD | new | Q2 2020 1 quarter |
| Anaplan Inc | 1.1% | 5,746,829 | 260.4M USD | +4,823.5% increased | Q4 2019 3 quarters |
| Guardant Health Inc | 1.1% | 3,068,173 | 248.9M USD | −19.2% reduced | Q3 2019 4 quarters |
| ADI Analog Devices | 1.0% | 1,959,943 | 240.4M USD | new | Q2 2020 1 quarter |
| LOW Lowe's | 1.0% | 1,710,360 | 231.1M USD | −68.7% reduced | Q2 2019 5 quarters |
| SHW Sherwin-Williams | 1.0% | 397,835 | 229.9M USD | new | Q2 2020 1 quarter |
| DRI Darden Restaurants | 1.0% | 2,991,636 | 226.7M USD | new | Q2 2020 1 quarter |
| Zentalis Pharmaceuticals Inc | 0.9% | 4,443,284 | 213.4M USD | new | Q2 2020 1 quarter |
| Exact Sciences Corp | 0.8% | 2,182,534 | 189.8M USD | −10.1% reduced | Q3 2018 8 quarters |
| SE Sea Limited (ADR) | 0.8% | 1,727,380 | 185.2M USD | +30.5% increased | Q4 2019 3 quarters |
| Molina Healthcare Inc | 0.8% | 1,013,668 | 180.4M USD | −25.8% reduced | Q3 2019 4 quarters |
| MU Micron Technology | 0.8% | 3,392,745 | 174.8M USD | −49.5% reduced | Q1 2020 2 quarters |
| ALL Allstate | 0.7% | 1,769,570 | 171.6M USD | new | Q2 2020 1 quarter |
| LIN Linde plc | 0.7% | 803,694 | 170.5M USD | new | Q2 2020 1 quarter |
| Encompass Health Corp | 0.7% | 2,677,612 | 165.8M USD | +85.2% increased | Q1 2020 2 quarters |
| NFLX Netflix | 0.7% | 356,549 | 162.2M USD | −86.6% reduced | Q3 2015 20 quarters |
| DHR Danaher Corporation | 0.7% | 903,929 | 159.8M USD | new | Q2 2020 1 quarter |
| BABA Alibaba Group (ADR) | 0.6% | 695,536 | 150.0M USD | new | Q2 2020 1 quarter |
| ALGN Align Technology | 0.6% | 539,343 | 148.0M USD | new | Q2 2020 1 quarter |
| Blueprint Medicines Corp | 0.5% | 1,629,716 | 127.1M USD | +1.8% increased | Q3 2018 8 quarters |
| Royalty Pharma PLC | 0.5% | 2,514,985 | 122.1M USD | new | Q2 2020 1 quarter |
| Catalent Inc | 0.5% | 1,493,703 | 109.5M USD | −22.9% reduced | Q1 2018 10 quarters |
| COO Cooper Companies (The) | 0.4% | 345,523 | 98.0M USD | −20.9% reduced | Q1 2020 2 quarters |
| Envista Holdings Corporation | 0.4% | 4,524,346 | 95.4M USD | new | Q2 2020 1 quarter |
| Avantor Inc | 0.4% | 5,475,379 | 93.1M USD | −45.5% reduced | Q2 2019 5 quarters |
| EG Everest Group | 0.4% | 418,223 | 86.2M USD | new | Q2 2020 1 quarter |
| Horizon Therapeutics Pub Ltd | 0.4% | 1,471,419 | 81.8M USD | −26.1% reduced | Q1 2020 2 quarters |
| CME CME Group | 0.3% | 482,679 | 78.5M USD | −71.6% reduced | Q1 2020 2 quarters |
| TJX TJX Companies | 0.3% | 1,519,986 | 76.9M USD | new | Q2 2020 1 quarter |
| Pvh Corporation | 0.3% | 1,522,984 | 73.2M USD | new | Q2 2020 1 quarter |
| MELI MercadoLibre | 0.3% | 69,344 | 68.4M USD | −82.2% reduced | Q1 2019 6 quarters |
| Bristol-Myers Squibb Co | 0.3% | 18,968,019 | 67.9M USD | −3.4% reduced | Q4 2019 3 quarters |
| Liberty Media Corp Del | 0.3% | 1,923,501 | 61.0M USD | unchanged | Q1 2017 14 quarters |
| Change Healthcare Inc | 0.2% | 4,326,999 | 48.5M USD | −66.1% reduced | Q1 2020 2 quarters |
| Viela Bio Inc | 0.2% | 1,049,000 | 45.4M USD | −16.1% reduced | Q4 2019 3 quarters |
| Varian Med Sys Inc | 0.2% | 365,827 | 44.8M USD | −57.8% reduced | Q1 2020 2 quarters |
| V Visa Inc. | 0.1% | 164,889 | 31.9M USD | −61.7% reduced | Q3 2016 16 quarters |
| Momenta Pharmaceuticals Inc | 0.1% | 946,220 | 31.5M USD | new | Q2 2020 1 quarter |
| Genmab A/S | < 0.1% | 575,086 | 19.5M USD | −31.6% reduced | Q3 2019 4 quarters |
| Agora Inc | < 0.1% | 400,000 | 17.7M USD | new | Q2 2020 1 quarter |
| Editas Medicine Inc | < 0.1% | 413,000 | 12.2M USD | −19.4% reduced | Q1 2016 18 quarters |
| Uniqure NV | < 0.1% | 62,396 | 2.8M USD | new | Q2 2020 1 quarter |
| Atyr Pharma Inc | < 0.1% | 587,444 | 2.6M USD | unchanged | Q3 2019 4 quarters |
| T-Mobile US Inc | < 0.1% | 1,799,550 | 302.0K USD | new | Q2 2020 1 quarter |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Financials 18.5%
- Consumer Discretionary 15.5%
- Health Care 14.1%
- Technology 8.0%
- Communication Services 7.2%
- Industrials 7.2%
- Materials 1.7%
- not in our coverage 27.8%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors